Home › Lung Cancer › NCT07168629
A Community Health Intervention to Improve Lung Cancer Screening Uptake in Community Health Centers
Who can join
Ages 50 to 80 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Adults between the age of 50 and 80. * Potentially eligible for LCS according to the Electronic Health Record smoking history. * Receive their primary care at Mason Square, High Street, or Brightwood community health centers. * English- or Spanish- speaking. Exclusion Criteria: * Not eligible for lung cancer screening based on age (age \< 50 or \> 80 years) or smoking history (has not smoked more than 20 pack-years of tobacco cigarettes or quit more than 15 years ago). * Have received a lung cancer screen in the past.
About the study
Lung cancer screening (LCS) can reduce lung cancer-related mortality, but screening uptake remains low among eligible individuals. The goal of this study is to partner with community stakeholders to develop and pilot test a multi-component navigator-delivered intervention targeting key barriers to lung cancer screening and tobacco treatment utilization. Participants are randomized to enhanced usual care, a community health worker (CHW)-delivered intervention, or the same intervention delivered by a trained lay navigator. The intervention includes patient outreach, patient-centered shared decision-making, tobacco treatment counseling, and assistance navigating logistical barriers to care. The proposed activities will lay the groundwork for a subsequent fully powered randomized clinical trial evaluating CHW- and lay navigator-delivered approaches to facilitate access to lung cancer screening and tobacco treatment.
What is being tested
- Community health worker delivered outreach, shared decision-making, tobacco treatment, and navigation (behavioral)
- Lay Navigator delivered outreach, shared decision-making, tobacco treatment, and navigation (behavioral)
- Enhanced Usual Care (other)
Sponsor: Baystate Medical Center · Participants: 120 · Started: May 10, 2026
Contact the study team
- Eduardo R Nunez, MD, MS · Phone: 1-855-794-5864
Official record on ClinicalTrials.gov — NCT07168629
Locations in the U.S.
| Massachusetts | Baystate Health, Springfield |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.